The sputum transcriptome better predicts COPD exacerbations after the withdrawal of inhaled corticosteroids than sputum eosinophils

INTRODUCTION: Continuing inhaled corticosteroid (ICS) use does not benefit all patients with COPD, yet it is difficult to determine which patients may safely sustain ICS withdrawal. Although eosinophil levels can facilitate this decision, better biomarkers could improve personalised treatment decisi...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :ERJ Open Res
Главные авторы: Ditz, Benedikt, Sarma, Aartik, Kerstjens, Huib A.M., Liesker, Jeroen J.W., Bathoorn, Erik, Vonk, Judith M., Bernal, Victor, Horvatovich, Peter, Guryev, Victor, Caldera, Saharai, Langelier, Chaz, Faiz, Alen, Christenson, Stephanie A., van den Berge, Maarten
Формат: Artigo
Язык:Inglês
Опубликовано: European Respiratory Society 2021
Предметы:
Original Research Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8255541/
https://ncbi.nlm.nih.gov/pubmed/34235210
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/23120541.00097-2021
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы